Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Coutelle

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Journal of Gene Medicine|May 3, 2008
Recent developments in adeno-associated virus vector technologyHildegard Büning, Luca Perabo, Oliver Coutelle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2014
Prognostic serum cytokines in classical Hodgkin lymphoma--letterOliver Coutelle, Hildegard Büning, Annette Plütschow, et al.
Onkologie|September 13, 2008
Complete remission in a colon cancer patient with a large, irresectable liver metastasis after XELOX/cetuximab/bevacizumab treatmentMartin R Weihrauch, Dirk Stippel, Jochen W U Fries, et al.
Virology|October 27, 2010
Intrinsic phospholipase A2 activity of adeno-associated virus is involved in endosomal escape of incoming particlesStefanie Stahnke, Kerstin Lux, Silke Uhrig, et al.
Discover Oncology|July 10, 2025
Impact of Nintedanib on tumor angiogenesis and vascular normalization in a mouse model of colorectal cancerNaita M Wirsik, Jens M Seeger, Thomas Schmidt, et al.
Cancer Investigation|December 17, 2011
Analysis of Tie2-expressing monocytes (TEM) in patients with colorectal cancerValentin Goede, Oliver Coutelle, Alexander Shimabukuro-Vornhagen, et al.
British Journal of Cancer|April 1, 2016
Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trialUlrich T Hacker, Laura Escalona-Espinosa, Nicola Consalvo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 29, 2010
Combined paracrine and endocrine AAV9 mediated expression of hepatocyte growth factor for the treatment of renal fibrosisStephanie Schievenbusch, Ingo Strack, Melanie Scheffler, et al.
Cancer Research|February 25, 2010
The proteasome inhibitor bortezomib sensitizes melanoma cells toward adoptive CTL attackJens Michael Seeger, Patrick Schmidt, Kerstin Brinkmann, et al.
Plos One|September 21, 2011
Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 inductionMonika Kwiecinski, Andrea Noetel, Natalia Elfimova, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Gene Medicine|May 3, 2008
Recent developments in adeno-associated virus vector technologyHildegard Büning, Luca Perabo, Oliver Coutelle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2014
Prognostic serum cytokines in classical Hodgkin lymphoma--letterOliver Coutelle, Hildegard Büning, Annette Plütschow, et al.
Onkologie|September 13, 2008
Complete remission in a colon cancer patient with a large, irresectable liver metastasis after XELOX/cetuximab/bevacizumab treatmentMartin R Weihrauch, Dirk Stippel, Jochen W U Fries, et al.
Virology|October 27, 2010
Intrinsic phospholipase A2 activity of adeno-associated virus is involved in endosomal escape of incoming particlesStefanie Stahnke, Kerstin Lux, Silke Uhrig, et al.
Discover Oncology|July 10, 2025
Impact of Nintedanib on tumor angiogenesis and vascular normalization in a mouse model of colorectal cancerNaita M Wirsik, Jens M Seeger, Thomas Schmidt, et al.
Cancer Investigation|December 17, 2011
Analysis of Tie2-expressing monocytes (TEM) in patients with colorectal cancerValentin Goede, Oliver Coutelle, Alexander Shimabukuro-Vornhagen, et al.
British Journal of Cancer|April 1, 2016
Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trialUlrich T Hacker, Laura Escalona-Espinosa, Nicola Consalvo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 29, 2010
Combined paracrine and endocrine AAV9 mediated expression of hepatocyte growth factor for the treatment of renal fibrosisStephanie Schievenbusch, Ingo Strack, Melanie Scheffler, et al.
Cancer Research|February 25, 2010
The proteasome inhibitor bortezomib sensitizes melanoma cells toward adoptive CTL attackJens Michael Seeger, Patrick Schmidt, Kerstin Brinkmann, et al.
Plos One|September 21, 2011
Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 inductionMonika Kwiecinski, Andrea Noetel, Natalia Elfimova, et al.
Pageof 2